Our community and our vision
Cambridge Cardiovascular is an Interdisciplinary Research Centre (IRC) funded by the University of Cambridge. We are a virtual Centre.
We aim to connect researchers across the Cambridge area, maximise opportunities for collaborative research, and nurture the next generation of research leaders. To this end we run Seminars and Workshops an Annual Symposium various Public Engagement Activities produce a monthly Newsletter and maintain online information for our community.
The IRC is led by Prof Martin Bennett and Prof James Rudd with guidance from a Steering group and Strategy Group spanning the Schools of Clinical Medicine, Biological Sciences, Humanities & Social Sciences, Physical Sciences, and Technology. The IRC Coordinator is Dr Jane Sugars and Sarah Gibbings its administrator.
- Subscribe to our newsletter to join our mailing list
- Contact webmaster@cardiovascular.cam.ac.uk to set up a basic Research profile page on our website. Provide your full name, CHRIS ID (if you are UoC staff or student), your email address and which of our categories you should be placed in (e.g. Academic staff, student etc). Once set up, members with a UoC CHRIS ID can update their existing profile. Members from outside the University of Cambridge, please contact webmaster@cardiovascular.cam.ac.uk who can edit your profile on your behalf.
Cardiovascular disease is the number one killer in UK and in most of the Western countries. It is already a huge burden to healthcare systems around the world, and improvements in the prevention, diagnosis, and effective treatment will be among the most pressing challenges within our aging populations in this century.
We will transform Cambridge into a world-leading hub for cardiovascular research. The foundation for this is provided through the integration of high quality pre-clinical and clinical research operating in a University-Hospital-Industry partnership. This partnership, now based in the VPD Heart & Lung Research Institute, is being driven by the re-location of the Royal Papworth Hospital and AstraZeneca global HQ and R&D facilities to the Cambridge Biomedical Campus.